ARCHIVES

In Brief: FDA’s Burlington Moves to Wyeth-Ayerst; NAS Award to Beckman; Genetics Online

This article is from The Cancer Letter archive.

Vol. 25 No. 05 | February 5, 1999

Download PDF Visit The Full Archive

Related Articles

Tamoxfin Trial accrues 6,000, Problems with Minority accrual Remain

April 2, 1993

Report Urges Better Working Conditions For Postdocs.

October 6, 2000

Ten Cooperative Group Chairs Propose Eight “Guiding Principles” For Change

May 20, 2011

Leukemia Society, NCI, Discuss Funding, Congressional Language On Centers In

January 14, 1994

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

In Brief: Willis Taylor New ACS President, Gerald Murphy President Elect, Robert Gadberry Bord Chairman

November 19, 1982